Skip to main content
PACIFIC EDGE LIMITED logo

PACIFIC EDGE LIMITED — Investor Relations & Filings

Ticker · PEB ISIN · NZPEBE0002S1 LEI · 9845007EDCF068FFEA12 ASX Professional, scientific and technical activities
Open in API
Filings indexed 749 across all filing types
Latest filing 2020-05-28 Regulatory Filings
Country NZ New Zealand
Listing ASX PEB

About PACIFIC EDGE LIMITED

https://www.pacificedgedx.com/

Pacific Edge Limited is a cancer diagnostics company specializing in the development and commercialization of non-invasive molecular diagnostic tests. The company's primary product suite, Cxbladder, utilizes advanced mRNA biomarker technology to detect and monitor bladder cancer from urine samples. These genomic tests are designed to assist clinicians in the evaluation of patients presenting with hematuria and in the ongoing surveillance of patients previously diagnosed with the disease. By providing high sensitivity and negative predictive value, the Cxbladder suite helps to accurately rule out urothelial carcinoma, potentially reducing the requirement for invasive clinical procedures such as cystoscopy. The company focuses on integrating its diagnostic tools into standard clinical pathways to improve patient outcomes and healthcare efficiency.

Recent filings

Filing Released Lang Actions
Amended: D&O Ongoing Disclosures – Multiple
Regulatory Filings
2020-05-28 English
Amended: Notice of Change in Issued Capital
Share Issue/Capital Change Classification · 100% confidence The document is a notice regarding the issuance of options to acquire ordinary shares, detailing the number of options issued, terms of issue, exercise price, and authority for the issue. It references Listing Rules and is focused on changes in issued capital related to employee incentive options. The document is short (4150 characters) and is an announcement of a capital change rather than a full financial report or detailed analysis. Therefore, it fits the category of Share Issue/Capital Change (SHA).
2020-05-28 English
PEB Full Year Result to be Announced 29 May 2020
Earnings Release Classification · 90% confidence The document is a short announcement dated 25 May 2020 advising that Pacific Edge Limited will release its full year results for the fiscal year ending 31 March 2020 on 29 May 2020. It includes details about an investor and analyst conference call and webcast to discuss the results. The document does not contain any actual financial data or detailed results but serves as a notification of the upcoming earnings release and related investor event. According to the 'MENU VS MEAL' rule, this is an announcement about a report (the full year results) rather than the report itself. Therefore, the appropriate classification is Earnings Release (ER), as it is the initial announcement of quarterly/periodical financial results (key highlights only). The document length is just over 5,000 characters but still primarily serves as a notice of the upcoming results and conference call, fitting the ER category rather than a full Annual Report or Interim Report. FY 2020
2020-05-25 English
PEB Investor Update – May 2020
Investor Presentation Classification · 90% confidence The document is an investor update from May 2020 discussing the company's operations during the COVID-19 pandemic, clinical utility of their product, recent healthcare provider adoptions, and upcoming annual results announcement for the fiscal year ended 31 March 2020. It does not contain actual financial statements or detailed financial analysis but rather provides business updates and operational highlights. It mentions that the annual results will be announced later, indicating this is a preparatory or informational communication rather than a formal financial report. The length is 8820 characters, which is substantial but the content is more of a business update/newsletter rather than a formal report like an Annual Report (10-K) or Interim Report (IR). Therefore, the best fitting category is Investor Presentation (IP) as it is a detailed presentation/update for investors focusing on business operations, strategy, and market position, but not a formal earnings release or annual report.
2020-05-03 English
Public Healthcare Providers increase use of Cxbladder
Capital/Financing Update Classification · 90% confidence The document is a press release dated 6 April 2020 from Pacific Edge Limited, a cancer diagnostics company, announcing the increased commercial use of their Cxbladder tests by public healthcare providers in New Zealand. It discusses the expansion of use, agreements with health boards, and the benefits of the tests, especially during the COVID-19 pandemic. There are no financial statements, regulatory filings, voting results, or management changes. The content is promotional and informative about commercial activities and product adoption rather than a formal financial or regulatory report. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is an announcement about commercial use and business development, which aligns best with a Capital/Financing Update (CAP) as it relates to commercial expansion and business activity updates. Confidence is high given the clear nature of the announcement and absence of financial or regulatory report content.
2020-04-06 English
Public Healthcare Providers increase use of Cxbladder
Regulatory Filings Classification · 95% confidence The document is a press release dated 6 April 2020 from Pacific Edge Limited, a cancer diagnostics company, announcing the increased commercial use of their Cxbladder tests by public healthcare providers in New Zealand. It discusses the expansion of commercial use, agreements with health boards, and the benefits of the tests, especially during the COVID-19 pandemic. There are no financial statements, regulatory filings, voting results, or management changes. The content is promotional and informative about commercial activities and product adoption rather than a formal financial or regulatory report. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is an announcement about commercial use and business development but not about capital raising or financing. Given the nature of the document as a corporate announcement about commercial use and business updates, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other categories.
2020-04-05 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.